LOTUS EYE HOSPITAL AND INSTITUTE
|
|
BOM : 532998     NSE : LOTUSEYE     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward Pledged Shares : NA |
Sep 06,2024 |
Price(EOD): ₹ 78.04
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 162.32 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
LOTUS EYE HOSPITAL AND INSTITUTE | 0.7% | 15% | -12.5% |
APOLLO HOSPITALS ENTERPRISE | 0.4% | 2.8% | 43.3% |
MAX HEALTHCARE INSTITUTE | 1.9% | 5% | 54.1% |
GLOBAL HEALTH | -1.7% | -6.7% | 61.7% |
FORTIS HEALTHCARE | -2.8% | 12.5% | 72.9% |
NARAYANA HRUDAYALAYA | 5.7% | 9.8% | 26.6% |
FUNDAMENTAL ANALYSIS OF LOTUS EYE HOSPITAL AND INSTITUTE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF LOTUS EYE HOSPITAL AND INSTITUTE
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
75.34
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 2.15 Cr
[Latest Qtr - Jun2024 - Standalone Results ] 2.73
P/B Calculated based on Book Value of Rs 59.41 Cr
[Latest Year - Mar2024 - Standalone Results ] 3.34
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
89% 66% 74% |
SHARE PRICE MOMENTUM OF LOTUS EYE HOSPITAL AND INSTITUTE
LOTUS EYE HOSPITAL AND INSTITUTE vs SENSEX
DEBT OF LOTUS EYE HOSPITAL AND INSTITUTE
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0 0 0 - |
- - - - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF LOTUS EYE HOSPITAL AND INSTITUTE
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF LOTUS EYE HOSPITAL AND INSTITUTE
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
18.45% 119.53% 14166.7% 2392% |
2.58% -30.08% -55.53% -54.99% |
QtrlyTrend |
2 | |
Latest Qtr: Jun2024 | ||
Quarterly Result Analysis → |
LOTUS EYE HOSPITAL AND INSTITUTE related INDICES
You may also like the below Video Courses
FAQ about LOTUS EYE HOSPITAL AND INSTITUTE
Is LOTUS EYE HOSPITAL AND INSTITUTE good for long term investment?
As on Sep 06,2024, the Fundamentals of LOTUS EYE HOSPITAL AND INSTITUTE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of LOTUS EYE HOSPITAL AND INSTITUTE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is LOTUS EYE HOSPITAL AND INSTITUTE UnderValued or OverValued?
As on Sep 06,2024, LOTUS EYE HOSPITAL AND INSTITUTE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of LOTUS EYE HOSPITAL AND INSTITUTE ?
As on Sep 06,2024, the Intrinsic Value of LOTUS EYE HOSPITAL AND INSTITUTE is Rs. 44.92 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 41.29
Fair Value [Median EV / Sales Model] : Rs. 47.02
Fair Value [Median Price / Sales Model] : Rs. 44.92
Estimated Median Fair Value of LOTUS EYE HOSPITAL AND INSTITUTE : Rs. 44.92
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.